PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rockwood K et al. – Despite evidence that links cognitive impairment to vascular risk factors, only a minority of clinical practice guidelines for the treatment of vascular risk factors consider cognition as either an adverse outcome or as a factor to consider in treatment.

Exclusive Author Commentary
Kenneth Rockwood, 11/06/09

The reason to treat vascular risk factors is to avoid damage to target organs, including the brain. Conventionally, such damage has been conceived of as stroke, especially motoric strokes. Cognition is also affected by vascular risk factors, but for historical reasons, has received much less recognition. This paper shows that most vascular risk factor guidelines ignore the impact on cognition. It notes too that cognitive impairment in this at risk group might affect medication adherence – and thereby increase risk. Perhaps now that the Hypertension in the Very Elderly Trial data have drawn attention to cognition and hypertension, we might see a change. For now, however, we are left with the vicious cycle of cognition not being studied in trials, so that we have little data about it, so that it is ignored in evidence-based clinical practice guidelines. This is just one example of how “evidence based” often is indistinguishable from “evidence-biased”.

   

Today in Clinical Guidelines...keeping you current

Guidelines for the proper use of epidural steroid injections for the chronic pain patient
Techniques in Regional Anesthesia and Pain Management, 11/20/09

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 11/17/09

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09

Today in Family Medicine...keeping you current

Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis
Cancer Causes and Control, 11/24/09

Understanding Omega-3 Polyunsaturated Fatty Acids
Postgraduate Medicine, 11/24/09

The Medical Risks of Obesity
Postgraduate Medicine, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address